Na-K-ATPase-inhibiting and glucose-6-phosphate dehydrogenase-stimulating activity of plasma and hypothalamus of the Okamoto spontaneously hypertensive rat
Abstract:The plasma of normal man and the rat, and an acetone extract of hypothalamus from the rat, have an ability to inhibit Na-K-ATPase which is related directly to salt intake. The ability of the plasma to inhibit Na-K-ATPase is raised in essential hypertension. The ability of plasma and of an acetone extract of hypothalamus from six spontaneously hypertensive (SHR) rats and six normotensive control (WKY) rats to inhibit Na-K-ATPase of fresh guinea-pig kidney was studied using cytochemical bioassay techniques. With… Show more
“…It is difficult to reconcile these ambiguous results concerning the Na + ,K + -ATPase inhibition with those of Millet et al, 21 who reported that, compared with that of WKY, plasma from SHR exerts a very marked stimulation of the activity of the renal glucose 6-phosphate dehydrogenase in fresh guinea pig kidney proximal tubule; this stimulation was usually associated with reciprocal changes in Na + ,K + -ATPase activity. They have also confirmed that SHR plasma does induce a transient inhibition of Na + ,K + -ATPase activity in the same cells.…”
Section: Discussionmentioning
confidence: 84%
“…The difference between these and our results cannot be explained by different Na + intakes, as with the diets of both their and our animals the urinary Na + excretion averaged 1 mmol/24 hr. Methodological differences are more likely to be involved, including the origin of the Na + ,K + -ATPase (rat or guinea pig semipurified enzyme or tissue slices), the amount of plasma studied (1.8 or down to 10~5), the time course of inhibition (stable or transient), and our use of deproteinized plasma, not whole plasma such as Millet et al 21 used, because of the high nonspecific inhibition observed with whole plasma under our experimental conditions. The results of these authors are, however, in agreement with the increased inhibition of Na + fluxes from erythrocytes and the high digoxinlike immunoreactivity of SHR plasma that we described.…”
Section: Discussionmentioning
confidence: 99%
“…The presence of high amounts of compound(s) able to inhibit the active Na + transport in plasma and hypothalamus of SHR has been recently reported on the basis of indirect or semiquantitative cytochemical assays. 21 In contrast, in vitro experiments on cell Na + transport did not confirm that active Na + transport inhibitors are present in SHR plasma. Studies of plasma-induced changes in Na + fluxes from erythrocytes, 22 -2 * white blood cells, or rat thymocytes 25 favor the participation of an inherited membrane defect in SHR, rather than the participation of a plasma substance.…”
SUMMARY Circulating digitalislike compounds have been proposed to be involved in some Na+ -dependent types of experimental hypertension and in human essential hypertension. The level of circulating Na + -K + pump inhibitor(s) was investigated in the spontaneously hypertensive rat of the Okamoto strain (SHR), its normotensive control, Wistar-Kyoto rat (WKY), and the regular Wistar rat using the following criteria: the ability of whole plasma to inhibit the total active Na + efflux from Wistar rat erythrocytes and to cross-react with digoxin antibodies and the ability of plasma extracts to inhibit Na + ,K + -adenosine triphosphatase (ATPase) activity of membranes from rat kidney. SHR plasma inhibited the net Na + efflux from Wistar erythrocytes by up to 27% compared with WKY or Wistar plasma. For a given number of cells, the inhibition increased with the amount of available plasma. Cross-reactivity with digoxin antibodies was twice as high in SHR as hi WKY or Wistar plasma. It was already enhanced in 3-to 4-week-old rats. Plasma extracts from SHR significantly inhibited Na + ,K + -ATPase activity when compared with WKY extracts (75.6 ± 2.6 vs 89.3 ± 2.4 /tmol P,/mg/hr; p < 0.01) but did not differ from Wistar plasma extracts. These results strongly suggest that circulating digitalislike compound(s) are present in elevated amounts hi SHR as early as 3 to 4 weeks of age, but their exact participation in blood pressure elevation or maintenance remains to be clarified.
“…It is difficult to reconcile these ambiguous results concerning the Na + ,K + -ATPase inhibition with those of Millet et al, 21 who reported that, compared with that of WKY, plasma from SHR exerts a very marked stimulation of the activity of the renal glucose 6-phosphate dehydrogenase in fresh guinea pig kidney proximal tubule; this stimulation was usually associated with reciprocal changes in Na + ,K + -ATPase activity. They have also confirmed that SHR plasma does induce a transient inhibition of Na + ,K + -ATPase activity in the same cells.…”
Section: Discussionmentioning
confidence: 84%
“…The difference between these and our results cannot be explained by different Na + intakes, as with the diets of both their and our animals the urinary Na + excretion averaged 1 mmol/24 hr. Methodological differences are more likely to be involved, including the origin of the Na + ,K + -ATPase (rat or guinea pig semipurified enzyme or tissue slices), the amount of plasma studied (1.8 or down to 10~5), the time course of inhibition (stable or transient), and our use of deproteinized plasma, not whole plasma such as Millet et al 21 used, because of the high nonspecific inhibition observed with whole plasma under our experimental conditions. The results of these authors are, however, in agreement with the increased inhibition of Na + fluxes from erythrocytes and the high digoxinlike immunoreactivity of SHR plasma that we described.…”
Section: Discussionmentioning
confidence: 99%
“…The presence of high amounts of compound(s) able to inhibit the active Na + transport in plasma and hypothalamus of SHR has been recently reported on the basis of indirect or semiquantitative cytochemical assays. 21 In contrast, in vitro experiments on cell Na + transport did not confirm that active Na + transport inhibitors are present in SHR plasma. Studies of plasma-induced changes in Na + fluxes from erythrocytes, 22 -2 * white blood cells, or rat thymocytes 25 favor the participation of an inherited membrane defect in SHR, rather than the participation of a plasma substance.…”
SUMMARY Circulating digitalislike compounds have been proposed to be involved in some Na+ -dependent types of experimental hypertension and in human essential hypertension. The level of circulating Na + -K + pump inhibitor(s) was investigated in the spontaneously hypertensive rat of the Okamoto strain (SHR), its normotensive control, Wistar-Kyoto rat (WKY), and the regular Wistar rat using the following criteria: the ability of whole plasma to inhibit the total active Na + efflux from Wistar rat erythrocytes and to cross-react with digoxin antibodies and the ability of plasma extracts to inhibit Na + ,K + -adenosine triphosphatase (ATPase) activity of membranes from rat kidney. SHR plasma inhibited the net Na + efflux from Wistar erythrocytes by up to 27% compared with WKY or Wistar plasma. For a given number of cells, the inhibition increased with the amount of available plasma. Cross-reactivity with digoxin antibodies was twice as high in SHR as hi WKY or Wistar plasma. It was already enhanced in 3-to 4-week-old rats. Plasma extracts from SHR significantly inhibited Na + ,K + -ATPase activity when compared with WKY extracts (75.6 ± 2.6 vs 89.3 ± 2.4 /tmol P,/mg/hr; p < 0.01) but did not differ from Wistar plasma extracts. These results strongly suggest that circulating digitalislike compound(s) are present in elevated amounts hi SHR as early as 3 to 4 weeks of age, but their exact participation in blood pressure elevation or maintenance remains to be clarified.
“…Absolute plasma vasopressin values obtained by the cytochemical bioassay were comparable to those measured by radioimmunoassay (r ¼ þ0.97, p < 0.001). This assay was later used to study hypertensive rats 41,42 and to determine the vasopressin levels in neonates. 43 One of the major drawbacks to these bioassays was the low throughput of the assay system.…”
“…W ITH the use of cytochemical techniques 12 we have previously demonstrated that plasma from normal humans 3 and rats 4 on a high sodium intake, from patients with essential hypertension, 3 and from adult spontaneously hypertensive rats (SHR) 6 have a heightened ability to inhibit Na + ,K + -adenosine triphosphatase (ATPase). It therefore appears that these two forms of hereditary hypertension are associated with a rise in the concentration of a cytochemically bioassayable circulating Na + ,K + -ATPase inhibitor that is controlled by salt intake in normal humans and animals.…”
SUMMARY The ability of plasma from 3-and 9-week-old Milan hypertensive rats and their nor motensive controls to inhibit Na + ,K+-adenosine triphosphatase (ATPase) was studied using cytochemical bioassay techniques in fresh tissue. With a validated cytochemical bioassay that measures the capacity of biological samples to stimulate glucose-6-phosphate dehydrogenase activity in guinea pig proximal tubules as an indication of their capacity to inhibit Na+,K+-ATPase, the mean gIucose-6-phosphate dehydrogenase-stimulating ability of the plasma of the 9-week-old Milan hypertensive rats and their normotensive controls was 586.0 ± 88 and 23.4 ± 8.3 U/ml (n = 7; p<0.001), while that of the 3-week-old Milan hypertensive rats (before the main rise in arterial pressure) and their normotensive controls was 99.9 ± 27.4and 7.8 ± 1.8 U/ml (n = 7; p<0.001). With the use of a semiquantitative cytochemical assay that measures Na+,K+-ATPase activity directly, plasma from the adult hypertensive rats had a much greater capacity to inhibit Na + ,K+-ATPase than the plasma of the control rats. The significantly raised levels found in the young hypertensive rats before the main rise in arterial pressure are consistent with the hypothesis that the rise hi the ability of plasma to inhibit Na+,K+-ATPase is due to an inherited renal difficulty in excreting sodium. (Hypertension 9:498-503, 1987) KEY WORDS • plasma • glucose-6-phosphate dehydrogenase-stimulating activity hypertensive rats • cytochemical assay • Na + ,K+-ATPase-inhibiting activity Milan
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.